These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11022952)

  • 1. Premature cardiovascular disease and chronic renal failure.
    Wardle EN
    Lancet; 2000 Sep; 356(9232):854-5. PubMed ID: 11022952
    [No Abstract]   [Full Text] [Related]  

  • 2. Premature cardiovascular disease in chronic renal failure.
    Baigent C; Burbury K; Wheeler D
    Lancet; 2000 Jul; 356(9224):147-52. PubMed ID: 10963260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal disease, homocysteine, and cardiovascular complications.
    Robinson K
    Circulation; 2004 Jan; 109(3):294-5. PubMed ID: 14744952
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperhomocysteinemia in chronic renal failure].
    Sydor A; Sułowicz W
    Przegl Lek; 1999; 56(7-8):520-4. PubMed ID: 10575921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hypertension and cardiovascular complications of chronic renal failure].
    Soucek M; Monhart V; Nedbálková M
    Vnitr Lek; 2011; 57(7-8):615-9. PubMed ID: 21877594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of dyslipidemia of chronic renal failure.
    Vaziri ND; Moradi H
    Hemodial Int; 2006 Jan; 10(1):1-7. PubMed ID: 16441821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemoglobin concentrations in chronic kidney disease.
    Fernandes M; Sawa H; Bellini G
    Lancet; 2007 Feb; 369(9559):365. PubMed ID: 17276763
    [No Abstract]   [Full Text] [Related]  

  • 8. Urotensin and cardiovascular risk among patients with end-stage renal disease: fact or fiction?
    Boos CJ; Lip GY
    Am J Hypertens; 2006 May; 19(5):511-2. PubMed ID: 16647625
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin D, cardiovascular disease and mortality in patients with kidney disease].
    Hansen D; Brandi L; Rasmussen K
    Ugeskr Laeger; 2009 Dec; 171(50):3684-9. PubMed ID: 20003863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-specific correlations of plasminogen activator inhibitor-1 and tissue plasminogen activator levels with cardiovascular disease-related traits.
    Asselbergs FW; Williams SM; Hebert PR; Coffey CS; Hillege HL; Navis G; Vaughan DE; van Gilst WH; Moore JH
    J Thromb Haemost; 2007 Feb; 5(2):313-20. PubMed ID: 17092303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular disease and chronic renal failure: new insights.
    Nanayakkara PW; Gaillard CA
    Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlling the epidemic of cardiovascular disease in chronic renal disease: report from the National Kidney Foundation Task Force on cardiovascular disease.
    Meyer KB; Levey AS
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S31-42. PubMed ID: 11443766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular disorders of chronic renal failure].
    Mijares R; Pérez Ramírez JL; Cornejo Barrera M
    Rev Clin Esp; 1977 Dec; 147(6):557-62. PubMed ID: 609804
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiovascular problems in ESRD patients.
    Lameire N
    Nefrologia; 2000; 20 Suppl 3():33-40. PubMed ID: 10835875
    [No Abstract]   [Full Text] [Related]  

  • 15. Leptin and plasminogen activator inhibitor-1 levels in children on chronic dialysis.
    Agras PI; Baskin E; Cengiz N; Haberal A; Ozbek N
    Ren Fail; 2013 Sep; 35(8):1079-84. PubMed ID: 23879619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular problems in chronic renal failure.
    Kotler MN; Segal BL
    Geriatrics; 1984 Jan; 39(1):69-70, 75-7, 81, 84. PubMed ID: 6690369
    [No Abstract]   [Full Text] [Related]  

  • 17. [Vitamin D deficiency in kidney failure. Risk factor for cardiovascular disease].
    Ohman K; Larsson T; Spaak J
    Lakartidningen; 2010 Nov 17-23; 107(46):2884-7. PubMed ID: 21197784
    [No Abstract]   [Full Text] [Related]  

  • 18. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Special report from the National Kidney Foundation Task Force on Cardiovascular Disease.
    Am J Kidney Dis; 1998 Nov; 32(5 Suppl 3):S1-199. PubMed ID: 9867706
    [No Abstract]   [Full Text] [Related]  

  • 19. Piecing together the evidence on anemia: the link between chronic kidney disease and cardiovascular disease.
    McCullough PA; Lepor NE
    Rev Cardiovasc Med; 2005; 6 Suppl 3():S4-12. PubMed ID: 16340933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bases of cardiovascular and hematological effects.
    Maduell F; Navarro V
    Hemodial Int; 2006 Jan; 10 Suppl 1():S39-42. PubMed ID: 16441867
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.